FRAG 176-191 5MG

PRODUCT DESCRIPTION

Growth hormone peptide fragment 176-19 is synthesised from the full protein which is capable of inducing weight loss and increasing fat breakdown following long-term treatment in subject studies

hGH Fragment 176-191 is a peptide fragment of the C-terminus of human Growth Hormone. Investigators at Monash University discovered that the fat-reducing effects of GH appear to be controlled by a small region near one end of the Growth Hormone molecule. This region, which consists of amino acids 176-191, is less than 10% of the total size of the GH molecule and appears to have no effect on growth or insulin resistance. Like Growth Hormone, the hgH fragment 176-191 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis (the transformation of nonfat food materials into body fat) both in laboratory testing and in animals.

Purity, Formulation & Physical Appearance

Fragment 176-191 has a peptide purity level that exceeds 99.0% as determined by HPLC. This peptide was synthesized with no additives and is supplied as a white lyophilized (freeze-dried) powder.

Solubility & Storage

It is recommended to reconstitute the lyophilized Fragment 176-191 in sterile water, which can then be further diluted in other aqueous solutions. Lyophilized Fragment 176-191 although stable at room temperature for 3-4 weeks, should be stored desiccated below -18°C. Upon reconstitution, Fragment 176-191 should be stored at 4°C out of direct light for between 10-14 days and for future use below -18°C. Prevent repeated freeze-thaw cycles.